Our mission is to build the leading AI-enabled biotech company, to reveal hidden biological mechanisms of disease and discover breakthrough drugs. By harnessing the power of causal AI, human multi-omics data, and our Gemini Digital Twins, we aim to accelerate the discovery of life-saving therapeutics to make a meaningful impact on the lives of patients.
At Aitia, derived from the Greek word for causality, we are rapidly turning aspiration into reality through the convergence of multi-omic patient data, high-performance computing, and causal AI. We are a team of world-class AI pioneers, R&D veterans, and biotech company builders backed by top-tier healthcare investors and strategic pharma leaders.
